Becton, Dickinson and Company (NYSE:BDX) Coverage Initiated at The Goldman Sachs Group

The Goldman Sachs Group began coverage on shares of Becton, Dickinson and Company (NYSE:BDXGet Free Report) in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm set a “buy” rating and a $274.00 price target on the medical instruments supplier’s stock. The Goldman Sachs Group’s price objective would suggest a potential upside of 18.08% from the company’s current price.

Separately, Barclays lifted their price objective on Becton, Dickinson and Company from $305.00 to $312.00 and gave the stock an “overweight” rating in a report on Monday, May 6th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $280.17.

Read Our Latest Analysis on BDX

Becton, Dickinson and Company Trading Up 2.3 %

NYSE BDX opened at $232.04 on Thursday. The stock’s 50-day simple moving average is $236.38 and its two-hundred day simple moving average is $237.81. Becton, Dickinson and Company has a twelve month low of $224.00 and a twelve month high of $287.32. The company has a quick ratio of 0.97, a current ratio of 1.41 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $67.06 billion, a price-to-earnings ratio of 51.11, a PEG ratio of 1.97 and a beta of 0.45.

Becton, Dickinson and Company (NYSE:BDXGet Free Report) last released its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $3.17 EPS for the quarter, topping the consensus estimate of $2.97 by $0.20. The firm had revenue of $5.05 billion for the quarter, compared to the consensus estimate of $5.04 billion. Becton, Dickinson and Company had a return on equity of 13.90% and a net margin of 6.76%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.86 earnings per share. Research analysts forecast that Becton, Dickinson and Company will post 13.03 EPS for the current fiscal year.

Insider Buying and Selling at Becton, Dickinson and Company

In other Becton, Dickinson and Company news, EVP Roland Goette sold 3,300 shares of Becton, Dickinson and Company stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $236.70, for a total transaction of $781,110.00. Following the sale, the executive vice president now directly owns 14,608 shares of the company’s stock, valued at approximately $3,457,713.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Becton, Dickinson and Company news, EVP Roland Goette sold 3,300 shares of Becton, Dickinson and Company stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $236.70, for a total transaction of $781,110.00. Following the sale, the executive vice president now directly owns 14,608 shares of the company’s stock, valued at approximately $3,457,713.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Michael David Garrison sold 1,715 shares of Becton, Dickinson and Company stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $232.81, for a total transaction of $399,269.15. Following the transaction, the executive vice president now owns 5,381 shares of the company’s stock, valued at $1,252,750.61. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,597 shares of company stock valued at $2,028,786. 0.31% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Becton, Dickinson and Company

Several large investors have recently made changes to their positions in BDX. Ridgewood Investments LLC raised its holdings in Becton, Dickinson and Company by 1.5% in the 1st quarter. Ridgewood Investments LLC now owns 2,956 shares of the medical instruments supplier’s stock worth $731,000 after acquiring an additional 43 shares during the last quarter. Key Client Fiduciary Advisors LLC raised its holdings in Becton, Dickinson and Company by 2.6% in the 1st quarter. Key Client Fiduciary Advisors LLC now owns 1,715 shares of the medical instruments supplier’s stock worth $424,000 after acquiring an additional 43 shares during the last quarter. Mendel Money Management raised its holdings in Becton, Dickinson and Company by 3.0% in the 3rd quarter. Mendel Money Management now owns 1,536 shares of the medical instruments supplier’s stock worth $397,000 after acquiring an additional 45 shares during the last quarter. CWM LLC raised its holdings in Becton, Dickinson and Company by 0.7% in the 4th quarter. CWM LLC now owns 6,303 shares of the medical instruments supplier’s stock worth $1,537,000 after acquiring an additional 46 shares during the last quarter. Finally, S.A. Mason LLC raised its holdings in Becton, Dickinson and Company by 3.5% in the 4th quarter. S.A. Mason LLC now owns 1,420 shares of the medical instruments supplier’s stock worth $346,000 after acquiring an additional 48 shares during the last quarter. 86.97% of the stock is currently owned by hedge funds and other institutional investors.

Becton, Dickinson and Company Company Profile

(Get Free Report)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

Further Reading

Analyst Recommendations for Becton, Dickinson and Company (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.